Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2922 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Lily’s Q2 income surges

The company reported worldwide sales of $5.15 billion in the second quarter of 2008, an increase of 11% compared with the $4.63 billion posted in the corresponding period

Bristol-Myers Squibb’s Q2 sales up

Pharmaceutical net sales totaled $4.5 billion and sales of nutritionals totaled $728 million in the second quarter of 2008, representing increases of 16% and 17%, respectively, compared to

Affymetrix reports Q2 losses

While the net loss reported in the second quarter of 2008 includes a pretax restructuring charge of $0.9 million or $0.01 per diluted share, the net income posted

Drug industry needs more fillip, says China

According to the document, there are approximately 6,900 pharmaceutical enterprises in China that are producing 1,500 types of drug substance and more than one billion doses of 41

Bayer Schering Pharma names new chairman

In addition, Bernd Metzner, currently head of finance at Bayer SpA, Italy, will assume responsibility for central administration and organization (CAO) at Bayer Schering Pharma (BSP) effective October